CA1028622A - Comprimes contenant dans leur masse des microcapsules retard et procede de fabrication de ces comprimes - Google Patents

Comprimes contenant dans leur masse des microcapsules retard et procede de fabrication de ces comprimes

Info

Publication number
CA1028622A
CA1028622A CA204,589A CA204589A CA1028622A CA 1028622 A CA1028622 A CA 1028622A CA 204589 A CA204589 A CA 204589A CA 1028622 A CA1028622 A CA 1028622A
Authority
CA
Canada
Prior art keywords
microcapsules
tablets
layer
new
layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA204,589A
Other languages
English (en)
French (fr)
Other versions
CA204589S (en
Inventor
Yvette Estevenel
Wladimir Coulon
Maurice Thely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Application granted granted Critical
Publication of CA1028622A publication Critical patent/CA1028622A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
CA204,589A 1973-07-12 1974-07-11 Comprimes contenant dans leur masse des microcapsules retard et procede de fabrication de ces comprimes Expired CA1028622A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7325531A FR2236483B1 (es) 1973-07-12 1973-07-12

Publications (1)

Publication Number Publication Date
CA1028622A true CA1028622A (fr) 1978-03-28

Family

ID=9122459

Family Applications (1)

Application Number Title Priority Date Filing Date
CA204,589A Expired CA1028622A (fr) 1973-07-12 1974-07-11 Comprimes contenant dans leur masse des microcapsules retard et procede de fabrication de ces comprimes

Country Status (11)

Country Link
US (1) US3922338A (es)
JP (1) JPS5736893B2 (es)
BE (1) BE817401A (es)
CA (1) CA1028622A (es)
DE (1) DE2433285C2 (es)
ES (1) ES428171A1 (es)
FR (1) FR2236483B1 (es)
GB (1) GB1469879A (es)
IT (1) IT1016413B (es)
NL (1) NL7409295A (es)
SE (1) SE419161B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
US4532123A (en) * 1982-03-04 1985-07-30 Battelle Development Corporation Dual Microcapsules and process for their preparation
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3228533A1 (de) * 1982-07-30 1984-02-02 Council of Scientific and Industrial Research, 110001 New Delhi Verfahren zur herstellung von medizinischen pillen und so hergestellen pillen
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
JPS61501197A (ja) * 1984-03-29 1986-06-19 レツペル−プラステイク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 印刷物の積み降ろし装置
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
EP0190833B1 (en) * 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
JPH0539288U (ja) * 1991-10-31 1993-05-28 三栄源エフ・エフ・アイ株式会社 容器兼用食品
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US6663896B1 (en) 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
DE10306468A1 (de) * 2003-02-14 2004-09-02 Henkel Kgaa Aus Pulver und Mikrokapseln gepreßter Formkörper
ATE401868T1 (de) * 2004-08-04 2008-08-15 Alza Corp ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß
US20080286344A1 (en) * 2007-05-16 2008-11-20 Olivia Darmuzey Solid form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US462990A (en) * 1891-11-10 William oppenheimek
DE646035C (de) * 1934-03-02 1937-06-07 Fritz Weinmann Dr Verfahren zur Herstellung von Arzneimitteltabletten aus mehreren Schichten
DE657259C (de) * 1936-05-20 1938-03-01 Ludwig Heumann & Co Chem Pharm Pressling fuer pharmazeutische Zwecke
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
FR5788M (es) * 1965-11-18 1968-03-18
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition

Also Published As

Publication number Publication date
IT1016413B (it) 1977-05-30
SE7409149L (sv) 1975-01-13
NL7409295A (nl) 1975-01-14
JPS5036619A (es) 1975-04-05
DE2433285A1 (de) 1975-01-30
GB1469879A (en) 1977-04-06
JPS5736893B2 (es) 1982-08-06
DE2433285C2 (de) 1985-02-07
SE419161B (sv) 1981-07-20
AU7117574A (en) 1976-01-15
ES428171A1 (es) 1976-07-16
FR2236483A1 (es) 1975-02-07
BE817401A (fr) 1975-01-09
US3922338A (en) 1975-11-25
FR2236483B1 (es) 1976-11-12

Similar Documents

Publication Publication Date Title
CA1028622A (fr) Comprimes contenant dans leur masse des microcapsules retard et procede de fabrication de ces comprimes
EP1273294B1 (fr) Composition pharmaceutique de fénofibrate présentant une biodisponibilité élévée et son procédé de préparation
CA2366027C (fr) Comprime orodispersible presentant une faible friabilite et son procede de preparation
CA2479057C (fr) Comprimes a base de microcapsules a liberation modifiee
CA2624372C (fr) Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
CA2446781C (fr) Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'angiotensine
EP0974365B1 (fr) Utilisation d'un polymère de type acrylique en tant qu'agent de désagrégation, procédé pour faire des comprimés et comprimés en résultant
RU2471480C2 (ru) Твердые или полужидкие дозированные формы с модифицированным высвобождением
EP1434572B1 (fr) Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
CA2629670C (fr) Forme galenique secable permettant une liberation modifiee du principe actif
WO1998009597A2 (en) Cushioning beads and tablet comprising the same capable of forming a suspension
FR2644343A1 (fr) Composition pharmaceutique solide comprenant de la nifedipine, et procede pour la preparer
EP3324943B1 (fr) Granules de mannitol pour compression directe
EP1478350B1 (en) Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core
Arunachalam et al. Fast dissolving drug delivery system: A review
WO2009138642A1 (fr) Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules
WO2004032942A1 (fr) Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
UA114412C2 (uk) Тверда дозована форма гіпурату (s)-2-аміно-3-(4-(2-аміно-6-((r)-1-(4-хлор-2-(3-метил-1h-піразол-1-іл)феніл)-2,2,2-трифторетокси)піримідин-4-іл)феніл)пропаноату
CA2299522C (fr) Composition diluante et desintegrante, son procede d'obtention et son utilisation
WO2005046647A1 (fr) Comprimes faiblement doses a reseau de polymeres
US4113816A (en) Process for the manufacture of layered tablets incorporating controlled-release microcapsules
MXPA05006203A (es) Formulaciones estables de topiramato.
EP1106646A1 (fr) Composition diluante et désintégrante, son procédé d'obtention et son utilisation
CA2802402A1 (fr) Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
WO2022123075A1 (fr) Comprimé à libération prolongée de la molsidomine